SICAGENBSESicagen India LtdLowNeutral
Announced Wed, 1 Oct · 17:33 IST

E-voting Results & Consolidated Scrutinizer''s Report for the 21st AGM of the Company

Board & Shareholder Meetings View source PDF

SICAGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sicagen India Ltd held its 21st Annual General Meeting on 30th September 2025 via video conferencing. E-voting was open from 25th to 29th September 2025 through the CDSL platform, with M/s. KRA & Associates acting as the Scrutinizer. All 7 resolutions were passed with near-unanimous approval — about 2.61 crore votes (99.99%) were cast in favor, with only 302 votes against. Key items approved include adoption of FY25 audited financial statements, declaration of an equity dividend for 2024-25, re-appointment of directors Mr. R. Chandrasekar and Mr. Ashwin C Muthiah (retiring by rotation), reappointment of Mr. Nandakumar Varma as Whole-Time Director for 3 more years, appointment of KRA & Associates as Secretarial Auditors for a 5-year term, and ratification of the Cost Auditor's remuneration for FY26.

Likely market impact

A routine, positive AGM outcome — shareholders approved the financial statements, confirmed a dividend payout, and endorsed all director appointments. No contentious resolutions or dissent, so minimal share-price impact expected beyond the already-anticipated dividend.